arrow_back Back Filing freshness 10-Q FY 2025 SEC EDGAR

LifeMD, Inc.

LFMD
$2.92 ▼ -0.13 (-4.43%) at close
Industrials ·Services-Offices & Clinics of Doctors of Medicine ·USServices-Offices & Clinics of Doctors of Medicine
15 Visible periods
28 Metrics
Peer-ranked Benchmarks
Price Chart
56
Health
Fair
Moderately Bullish
auto_awesome

Analytical Summary

LifeMD, Inc. demonstrates solid fundamentals with strength in Return on Common Equity (%). Overall, the data suggests a moderately positive outlook with manageable risks.

Market Cap $131.8M
Dividend Yield —
Revenue Growth 25.3% ↗
Op. Margin -4.0% ↗
ROIC -33.3% ↘
FCF / Share $0.14 ↘
Trailing P/E 11.7x
Price / Book 5.9x
FCF Yield 4.9%
Debt / Equity —
info Valuation on last close. End-of-day price, Sep 24, 2026.

15-Year Financial Trajectory

Annual
Metric Value Trend Year over Year Percentile
Revenue Total top-line sales
$194.06M
↑ +25.3% —
Net Income Profit after all expenses
$14.35M
↑ +167.0% —
Operating Margin Operating profit as % of sales
-4.0%
↑ +70.0% 21th
FCF / Share Free cash flow per share
$0.14
↓ -63.5% —
trending_up

Bullish Indicators

  • Return on Common Equity (%)Return on Common Equity (%) is in the top quartile
warning

Bearish Risks

  • Operating Margin (%)Operating Margin (%) is in the bottom quartile

Health Breakdown

Profitability ↑
38
Returns
98
Financial Health ↑
35
Cash Quality ↓
38

bar_chart Data from SEC EDGAR XBRL filings

Synced 2 days ago 15 years · 59 quarters